Beurer, Germany. Compact & USB Rechargeable Nebuliser for Adults & Children with 3.5-Hour Battery Life - Ideal for On-the-Go and Loadshedding
Highlights:
Nebulisation using vibrating membrane technology.
Intelligent aerosol technology – effective application due to nebulization stop during exhalation.
Lithium-ion battery with a battery working time of approx. 3.5 hours.
Features:
Increase your well-being through inhalation.
The Beurer inhaler IH 57 with oscillating membrane technology can relieve symptoms of asthma, colds and respiratory diseases.
The intelligent aerosol technology stops nebulization during exhalation and ensures even more efficient inhalation.
For the treatment of the upper and lower respiratory tract
For use with colds, asthma, respiratory diseases, etc. - for quick and effective inhalation
High Respiratory Particulate Content (MMAD): 4.52 μm
High nebulization performance (low nebulization rate: ≥0.2 ml/min, high nebulization rate: ≥0.4 ml/min) - short inhalation time
Can be flexibly swivelled up to 45°
Ideal for children and suitable for travel / on-the-go.
Hygienic processing thanks to self-cleaning function
Whisper quiet (approx. 45 dB(A))
Medical device: This device is medically certified, so that you can be confident in getting effective home treatment.
What's in the Box
Nebuliser
Mesh atomiser with medication container
Mouthpiece
Adult mask
Children's mask
Storage bag
Micro USB cable
Spare Parts / Accessories Year Pack for the IH 57 Nebuliser are available for purchase separately (item code 601.43 / SKU: IH 57 SPARE). As with any plastic parts, atomisers and their accessories are affected by a certain amount of wear and tear when used and hygienically prepared on a frequent basis. We therefore recommend that you replace the atomiser and other spare parts after a year.
Specifications:
Product measurements (LxWxH): 46 x 78 x 108 mm
Product weight: approx. 109 g
5-year limited warranty
Item no. / SKU: 601.42 / IH 57
Inhalation is the most effective way to administer medication for most respiratory system conditions for the following reasons:
The medication is transported directly to the target organs,
The local bioavailability of the medication is significantly increased,
Systemic diffusion is reduced substantially,
Only very low doses of the medication are required,
Quick and effective therapeutic effect,
Side effects are significantly reduced compared to systemic administration,
Humidifying of the airways,
Loosening and making (bronchial) secretions more liquid,
Releasing bronchospasms (spasmolysis),
Relieving swollen and inflamed bronchial mucosa,
Coughing up secretions,
Fighting viruses that affect the upper and lower airways.
The nebuliser can be used for diseases of the upper and/or lower airways including rhinitis, allergic rhinitis, sinusitis, pharyngitis and laryngitis.
Also, bronchial asthma, bronchitis, COPD (chronic obstructive pulmonary disease), bronchiectasis, acute tracheobronchitis, cystic fibrosis and pneumonia.
